Invention Grant
- Patent Title: Chlamydia antigens
-
Application No.: US14831535Application Date: 2015-08-20
-
Publication No.: US09675683B2Publication Date: 2017-06-13
- Inventor: Guido Grandi , Renata Maria Grifantini , Oretta Finco
- Applicant: Glaxosmithkline Biologicals SA
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
- Current Assignee Address: BE Rixensart
- Main IPC: A61K39/118
- IPC: A61K39/118 ; C07K14/295 ; A61K39/395 ; G01N33/569 ; C07K16/12 ; A61K39/00
Abstract:
The invention provides Chlamydia antigens for use in the treatment, prevention and/or diagnosis of Chlamydia infection. In particular, the invention provides antigens CT733, CT153, CT601, CT279, CT443, CT372, CT456, CT381, CT255, CT341, CT716, CT745, CT387, CT812, CT869, CT166, CT175, CT163, CT214, CT721, CT127, CT043, CT823 and/or CT600 from C. trachomatis for the treatment, prevention or diagnosis of Chlamydia infection.
Public/Granted literature
- US20160158337A1 CHLAMYDIA ANTIGENS Public/Granted day:2016-06-09
Information query
